Respiratory syncytial virus: How, why and what to do

Journal of Infection

Volumn 68, Issue SUPPL1, 2014, Pages

  Rodriguez, Rosa ^a   Ramilo, Octavio ^b  

^a HOSPITAL MATERNO INFANTIL GREGORIO MARAÑÓN   (Spain)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Bronchiolitis; Palivizumab; Respiratory Syncytial Virus, RSV; RNAi; Viral coinfections

Indexed keywords

25 HYDROXYVITAMIN D; ALN RSV 01; MOTAVIZUMAB; PALIVIZUMAB; PLACEBO; PREDNISOLONE; SMALL INTERFERING RNA; VITAMIN D;

ADENOVIRUS; AGE DISTRIBUTION; ANTIVIRAL ACTIVITY; ARTICLE; BRONCHIOLITIS; BRONCHIOLITIS OBLITERANS; CHILDHOOD MORTALITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG APPROVAL; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HUMAN METAPNEUMOVIRUS; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; LOWER RESPIRATORY TRACT INFECTION; LUNG TRANSPLANTATION; MIXED INFECTION; MOLECULAR DIAGNOSIS; PATHOGEN LOAD; PNEUMOVIRUS INFECTION; PREGNANCY; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RHINOVIRUS; RISK FACTOR; RISK REDUCTION; RNA INTERFERENCE; SEASONAL VARIATION; SKIN MANIFESTATION; ULTRAVIOLET B RADIATION; VIRUS CULTURE; VIRUS IDENTIFICATION; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS STRAIN; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WHEEZING;

BRONCHIOLITIS; PALIVIZUMAB; RESPIRATORY SYNCYTIAL VIRUS, RSV; RNAI; VIRAL COINFECTIONS;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIVIRAL AGENTS; BRONCHIOLITIS; CHEMOPREVENTION; CHILD, PRESCHOOL; COINFECTION; DRUG DISCOVERY; HUMANS; INFANT; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 84889689385     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.09.021     Document Type: Article

References (30)

1. Collins P.L., Graham B.S. Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol 2008, 82:2040-2055.
2. Nair H., et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010, 375(9725):1545-1555.
3. Simoes E.A. Respiratory syncytial virus infection. Lancet 1999, 354(9181):847-852.
4. Zhou H., et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis 2012, 54(10):1427-1436.
5. Garcia C.G., et al. Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. Pediatrics 2010, 126(6):e1453-e1460.
6. Camargo C.A., et al. Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics 2011, 127(1):e180-e187.
7. Jartti T., et al. Low serum 25-hydroxyvitamin D levels are associated with increased risk of viral coinfections in wheezing children. J Allergy Clin Immunol 2010, 126(5):1074-1076. 1076.e1-4.
8. Belderbos M.E., et al. Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics 2011, 127(6):e1513-e1520.
9. Camargo C.A., et al. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics 2012, 130(3):e561-e567.
10. Miron D., et al. Sole pathogen in acute bronchiolitis: is there a role for other organisms apart from respiratory syncytial virus?. Pediatr Infect Dis J 2010, 29(1):e7-e10.
11. Richard N., et al. The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis. Pediatr Infect Dis J 2008, 27(3):213-217.
12. Semple M.G., et al. Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J Infect Dis 2005, 191(3):382-386.
13. Calvo C., et al. Detection of new respiratory viruses in hospitalized infants with bronchiolitis: a three-year prospective study. Acta Paediatr 2010, 99(6):883-887.
14. Brand H.K., et al. Infection with multiple viruses is not associated with increased disease severity in children with bronchiolitis. Pediatr Pulmonol 2012, 47(4):393-400.
15. Stempel H.E., et al. Multiple viral respiratory pathogens in children with bronchiolitis. Acta Paediatr 2009, 98(1):123-126.
16. Mansbach J.M., et al. Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc Med 2012, 166(8):700-706.
17. DeVincenzo J.P., El Saleeby C.M., Bush A.J. Respiratory syncytial virus load predicts disease severity in previously healthy infants. J Infect Dis 2005, 191(11):1861-1868.
18. Sheeran P., et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J 1999, 18(2):115-122.
19. Wright P.F., et al. Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. J Infect Dis 2002, 185(8):1011-1018.
20. Fodha I., et al. Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity. J Med Virol 2007, 79(12):1951-1958.
21. Houben M.L., et al. Disease severity and viral load are correlated in infants with primary respiratory syncytial virus infection in the community. J Med Virol 2010, 82(7):1266-1271.
22. Marguet C., et al. In very young infants severity of acute bronchiolitis depends on carried viruses. PLoS One 2009, 4(2):e4596.
23. Martin E.T., et al. Clinical disease and viral load in children infected with respiratory syncytial virus or human metapneumovirus. Diagn Microbiol Infect Dis 2008, 62(4):382-388.
24. El Saleeby C.M., et al. Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children. J Infect Dis 2011, 204(7):996-1002.
25. Lehtinen P., et al. Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema. J Allergy Clin Immunol 2007, 119(3):570-575.
26. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998, 102(3):531-537.
27. Carbonell-Estrany X., et al. Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial. Pediatrics 2010, 125(1):e35-e51.
28. Bitko V., et al. Inhibition of respiratory viruses by nasally administered siRNA. Nat Med 2005, 11(1):50-55.
29. DeVincenzo J., et al. A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc Natl Acad Sci U S A 2010, 107(19):8800-8805.
30. Zamora M.R., et al. RNA interference therapy in lung transplant patients infected with respiratory syncytial virus. Am J Respir Crit Care Med 2011, 183(4):531-538.